| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/10/2001 | WO2001032861A1 Tumour suppressor genes from chromosome 16 |
| 05/10/2001 | WO2001032860A1 Transcriptional activators |
| 05/10/2001 | WO2001032859A1 Novel tumor suppressor gene |
| 05/10/2001 | WO2001032856A2 Seed-preferred promoter from barley |
| 05/10/2001 | WO2001032852A2 Method for directed packaging of molecular substances in protein shells |
| 05/10/2001 | WO2001032851A2 Modular transport systems for molecular substances and production and use thereof |
| 05/10/2001 | WO2001032844A1 Microtiter plate (mtp) based high throughput screening (hts) assays |
| 05/10/2001 | WO2001032837A1 19 human secreted proteins |
| 05/10/2001 | WO2001032833A2 Monalisa, a g-protein coupled receptor |
| 05/10/2001 | WO2001032714A1 Recombinant fusion molecules |
| 05/10/2001 | WO2001032711A2 Adeno-associated virus aav rep78 major regulatory protein, mutants thereof and uses thereof |
| 05/10/2001 | WO2001032710A1 Dog and rabbit motilin receptor orthologs |
| 05/10/2001 | WO2001032709A2 Polypeptides with non-natural primary signalling motifs |
| 05/10/2001 | WO2001032708A1 Compounds, antibodies and methods for treating, preventing or diagnosing tumour metastasis |
| 05/10/2001 | WO2001032707A1 Human semaphorin |
| 05/10/2001 | WO2001032706A2 Novel human transporter proteins and polynucleotides encoding the same |
| 05/10/2001 | WO2001032705A1 Ghsr ligand polypeptides and dnas thereof |
| 05/10/2001 | WO2001032704A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | WO2001032703A1 Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| 05/10/2001 | WO2001032702A2 Molecular structure of rhd negative locus |
| 05/10/2001 | WO2001032698A1 A novel polypeptide-human autoimmune disease associated protein 16 and the polynucleotide encoding said polypeptide |
| 05/10/2001 | WO2001032697A2 Virulence genes and proteins from brucella melitensis, and their use |
| 05/10/2001 | WO2001032696A2 Traf family proteins |
| 05/10/2001 | WO2001032695A2 MODULATION OF eNOS ACTIVITY AND THERAPEUTIC USES THEREOF |
| 05/10/2001 | WO2001032693A2 Trp-protein-related mtr1 protein and dna sequence coding therefor |
| 05/10/2001 | WO2001032692A2 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
| 05/10/2001 | WO2001032688A1 Renilla reniformis green fluorescent protein |
| 05/10/2001 | WO2001032687A1 10 human secreted proteins |
| 05/10/2001 | WO2001032684A2 Method for linking molecular substances based on the affinity of the proline-rich amino acid sequences and protein domains of type ww |
| 05/10/2001 | WO2001032678A1 sbgFGF-19a |
| 05/10/2001 | WO2001032677A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | WO2001032676A1 25 human secreted proteins |
| 05/10/2001 | WO2001032675A1 32 human secreted proteins |
| 05/10/2001 | WO2001032674A1 26 human secreted proteins |
| 05/10/2001 | WO2001032614A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | WO2001032289A1 Methods for preparing blood or plasma component solutions with improved concentrations |
| 05/10/2001 | WO2001032222A1 Selective toxin expression in angiogenic endothelial cells |
| 05/10/2001 | WO2001032220A1 Gene therapy for diabetic ischemic disease |
| 05/10/2001 | WO2001032204A2 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 05/10/2001 | WO2001032197A2 Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders |
| 05/10/2001 | WO2001032196A1 Secretin fragments for treating autism |
| 05/10/2001 | WO2001032193A1 Cytotoxic t lymphocyte-stimulating peptides for prevention, treatment, and diagnosis of melanoma |
| 05/10/2001 | WO2001032128A2 Human chemokine beta-13 |
| 05/10/2001 | WO2001032022A1 YtgP |
| 05/10/2001 | WO2001032021A1 ytgp |
| 05/10/2001 | WO2001032002A1 Myb transcription factors and uses thereof |
| 05/10/2001 | WO2001021806B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2001021804B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2001021803B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2001021270A3 Methods for producing recombinant proteins |
| 05/10/2001 | WO2001007469A3 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 05/10/2001 | WO2001005974A3 The il-1l1 gene and polypeptide products |
| 05/10/2001 | WO2001005824A3 Synthetic peptides immunoreactive with hepatitis a virus antibodies |
| 05/10/2001 | WO2001000801A3 Gene involved in epigenetic gene silencing |
| 05/10/2001 | WO2000077207A3 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 05/10/2001 | WO2000077035A3 Novel potassium channels and genes encoding these potassium channels |
| 05/10/2001 | WO2000072690A3 IMMOBILIZED LACTOFERRIN (Im-LF) ANTIMICROBIAL AGENTS AND USES THEREOF |
| 05/10/2001 | WO2000072666A3 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE |
| 05/10/2001 | WO2000064488A3 Somatic transgene immunization and related methods |
| 05/10/2001 | WO2000063435A8 Method of identifying toxic agents using differential gene expression |
| 05/10/2001 | WO2000063241A3 Methods and compositions for modulating an immune response |
| 05/10/2001 | WO2000061170A3 Novel medical use of alpha-1-acidic glycoprotein (aag or orosomucoid) |
| 05/10/2001 | WO2000061067B1 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 05/10/2001 | WO2000034489A9 Major basic protein deficient animals |
| 05/10/2001 | WO2000034334A9 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 05/10/2001 | WO2000012711A8 Human membrane channel proteins |
| 05/10/2001 | US20010001061 Assay for disease related conformation of a protein |
| 05/10/2001 | US20010001058 Method for identifying substance capable of disrupting interaction between herpes simplex virus ICP34.5 polypeptide or homologue thereof, or derivative thereof, and proliferating cell nuclear antigen or a homologue thereof; viricides |
| 05/10/2001 | US20010001040 Alteration of macrophage-induced T cell suppression or concentration by the selective elimination or increase of tryptophan by administering an enzyme inhibitor of indole-amino 2,3-deoxygenase; viricides; abortion; fertility; |
| 05/10/2001 | DE19953607A1 Production of crosslinked bacteriorhodopsin in membrane-bound form, useful in photoelectric applications and for data storage, by treatment with transglutaminase |
| 05/10/2001 | DE19952622A1 Verfahren zur Herstellung von rekombinantem Interleukin-8 und Interleukin-8 Muteinen A process for producing recombinant Interleukin-8 and Interleukin-8 muteins |
| 05/10/2001 | CA2391139A1 Transcriptional activators |
| 05/10/2001 | CA2390387A1 Method of diagnosing rheumatoid arthritis |
| 05/10/2001 | CA2390182A1 Novel human transporter proteins and polynucleotides encoding the same |
| 05/10/2001 | CA2390180A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | CA2390017A1 Cell surface display of proteins by recombinant host cells |
| 05/10/2001 | CA2389921A1 Plant photoperiod sensitivity gene hd1 and use of the same |
| 05/10/2001 | CA2389765A1 Cpg receptor (cpg-r) and methods relating thereto |
| 05/10/2001 | CA2389759A1 Seed-preferred promoter from barley |
| 05/10/2001 | CA2389754A1 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | CA2389751A1 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | CA2389690A1 Selective toxin expression in angiogenic endothelial cells |
| 05/10/2001 | CA2389680A1 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 05/10/2001 | CA2389676A1 Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| 05/10/2001 | CA2389672A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | CA2389644A1 A novel polypeptide hormone phosphatonin |
| 05/10/2001 | CA2389615A1 Insulin-responsive sequence dna binding protein-1" (irsdbp-1), gene encoding it and uses thereof |
| 05/10/2001 | CA2389600A1 Novel human melastatin-like proteins and polynucleotides encoding the same |
| 05/10/2001 | CA2389575A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 05/10/2001 | CA2389574A1 Ghsr ligand polypeptides and dnas thereof |
| 05/10/2001 | CA2389415A1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | CA2389390A1 Starch branching enzymes |
| 05/10/2001 | CA2389383A1 Educational kit and method containing novel alpha helical protein-34 |
| 05/10/2001 | CA2389339A1 Recombinant therapeutic fusion proteins |
| 05/10/2001 | CA2389329A1 Dog and rabbit motilin receptor orthologs |
| 05/10/2001 | CA2389283A1 Methods for preparing blood or plasma component solutions with improved concentrations |
| 05/10/2001 | CA2389062A1 Human protein which binds to human tyrosine kinase hck, and gene encoding the same |
| 05/10/2001 | CA2389058A1 Novel tumor suppressor gene |
| 05/10/2001 | CA2388982A1 Microtiter plate (mtp) based high throughput screening (hts) assays |
| 05/10/2001 | CA2388955A1 Recombinant fusion molecules |